To determine whether experimentally perturbing levels of high-confidence PSP glial genes would impact tau-related neurodegeneration, we carried out a knockdown screening experiment with the 21 genes using a Drosophila model of tauopathy with GMR-Gal4 driver20. The gene discussed is MAPT; the disease is tauopathy.